Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma
Clinical trial NCT03226392 · COMPLETED
Trial details
- NCT number
- NCT03226392
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-31
- Primary completion
- 2019-07-05
- Enrollment
- 704
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.